Description

Dostinex (cabergoline) tablets 0.5 mg. №2

Ingredients

Active ingredient: Cabergoline 0.5 mg per tablet.

Dosage

Dosage: The usual recommended dose is 0.5 mg twice a week. Dosage may vary based on individual needs and medical condition.

Indications

Indications: Dostinex tablets are indicated for the treatment of hyperprolactinemia, disorders associated with high levels of prolactin hormone.

Contraindications

Contraindications: Do not use Dostinex if you are allergic to cabergoline or any other ingredients in the product. It is important to consult a healthcare provider before starting this medication.

Directions

Directions: Take Dostinex tablets orally with or without food as directed by your doctor. Follow the prescribed dosage and do not exceed it.

Scientific Evidence

Dostinex (cabergoline) tablets 0.5 mg have been extensively studied for their efficacy in treating hyperprolactinemia. Clinical trials have shown that cabergoline effectively reduces prolactin levels in patients with hyperprolactinemia, leading to improvements in associated symptoms such as menstrual irregularities and infertility.

Research published in the Journal of Clinical Endocrinology & Metabolism demonstrated the superior efficacy of cabergoline compared to other dopamine agonists in normalizing prolactin levels and restoring gonadal function in patients with hyperprolactinemia.

Additional Information

• Storage: Store Dostinex tablets at room temperature away from light and moisture.
• Pregnancy: It is important to discuss the risks and benefits of using Dostinex during pregnancy with your healthcare provider.